Biomarker, Innovation, Research
November 3, 2022
Via: Medical Device NetworkDutch company Enzyre has raised $11.85m (€12m) in a Series A financing round to accelerate the development of its ambulant diagnostic technology platform for haemophilia patients. Led by new investor Oost NL, the financing round also saw participation from Demcon […]
October 23, 2018
Via: The Medical NewsScientists at the Center for Infection and Immunity (CII) in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence […]
March 28, 2024
April 19, 2024
Copyright © 2024. All rights reserved
